Evidence map›Paper›PMID 36985703›Full record

ArticleMolecules (Basel, Switzerland)2023

One-Pot Radiosynthesis of [

Viktoriya V Orlovskaya, Olga S Fedorova, Nikolai B Viktorov, Daria D Vaulina, Raisa N Krasikova

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Review
  3. Radiopharmaceuticals and their applications in medicine.Signal transduction and targeted therapy · 2025
    Review
  4. Simple and Efficient Synthesis ofPharmaceuticals (Basel, Switzerland) · 2024
    Article
  5. Review
  6. Automation of Copper-MediatedMolecules (Basel, Switzerland) · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Viktoriya V OrlovskayaN.P. Bechtereva Institute of the Human Brain, Russian Academy of Science, 197376 St. Petersburg, Russia.
Olga S FedorovaN.P. Bechtereva Institute of the Human Brain, Russian Academy of Science, 197376 St. Petersburg, Russia.
Nikolai B ViktorovSt. Petersburg State Technological Institute, Technical University, 190013 St. Petersburg, Russia.ORCID 0000-0002-8369-2537
Daria D VaulinaN.P. Bechtereva Institute of the Human Brain, Russian Academy of Science, 197376 St. Petersburg, Russia.ORCID 0000-0003-1088-2396
Raisa N KrasikovaN.P. Bechtereva Institute of the Human Brain, Russian Academy of Science, 197376 St. Petersburg, Russia.ORCID 0000-0002-4201-7949
Institute of the Human Brain · RUSt. Petersburg State Technological Institute · RU

Funding

Russian Foundation of Basic Researches 20-53-12030\22
6 · The paper itself

Abstract

Availability of PET imaging radiotracers targeting α-synuclein aggregates is important for early diagnosis of Parkinson's disease and related α-synucleinopathies, as well as for the development of new therapeutics. Derived from a pyrazole backbone,

Indexed as

alpha-SynucleinFluorine RadioisotopesAnimalsBenzodioxolesPositron-Emission TomographyPyrazoles3-(1,3-benzodioxol-5-yl)-5-(3-bromophenyl)-1H-pyrazolealpha-SynucleinBenzodioxolesFluorine RadioisotopesPyrazoles[18F]anle138b6-[18F]fluoropiperonalfluorine-18one-pot synthesisradiofluorinationα-synuclein

Identifiers

PMID36985703
PMCPMC10052605
OpenAlexW4327973095

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.